The current price is in 42,61$, In this post we are going to talk about the listed company Ultragenyx, its leaders are Camille L. Bedrosian (Chief Medical Officer & Executive Vice President), Dennis Karl Huang (Chief Technical Operations Officer & Senior VP), Emil D. Kakkis (President, Chief Executive Officer & Director), Mardi C. Dier (Chief Financial Officer & Executive Vice President), Thomas Richard Kassberg (Chief Business Officer & Executive Vice President), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Today this action begins with yesterday's closing price, desconocido$.
The current range on the same day is from 41,15$ - 43,00$, with a percentage difference of 42,08$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The last value we have registered for the opening is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
